STEIN GOLD, L.; BAGEL, J.; TYRING, S. K.; HONG, C.- ho; PAVLOVSKY, L.; PINTER, A.; REICH, A.; DROGARIS, L.; WU, T.; PHOTOWALA, H.; STAKIAS, V. .; RICHTER, S.; PAPP, K. Efficacy and Safety of Risankizumab Compared with Apremilast in Patients with Moderate Plaque Psoriasis: Mean PASI and BSA Results From the Phase 4 IMMpulse Trial. SKIN The Journal of Cutaneous Medicine, [S. l.], v. 7, n. 6, p. s257, 2023. DOI: 10.25251/skin.7.supp.257. Disponível em: https://jofskin.org/33014/index.php/skin/article/view/2404. Acesso em: 3 jul. 2024.